Niagen Bioscience (NASDAQ:NAGE – Get Free Report) and Herbalife (NYSE:HLF – Get Free Report) are both small-cap consumer staples companies, but which is the better business? We will compare the two companies based on the strength of their dividends, risk, institutional ownership, profitability, valuation, earnings and analyst recommendations.
Profitability
This table compares Niagen Bioscience and Herbalife’s net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| Niagen Bioscience | 12.39% | 17.95% | 13.17% |
| Herbalife | 3.16% | -43.90% | 7.89% |
Valuation and Earnings
This table compares Niagen Bioscience and Herbalife”s top-line revenue, earnings per share (EPS) and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| Niagen Bioscience | $129.08 million | 1.51 | $17.38 million | $0.18 | 13.56 |
| Herbalife | $5.04 billion | 0.28 | $228.30 million | $1.55 | 8.58 |
Herbalife has higher revenue and earnings than Niagen Bioscience. Herbalife is trading at a lower price-to-earnings ratio than Niagen Bioscience, indicating that it is currently the more affordable of the two stocks.
Analyst Recommendations
This is a summary of recent ratings for Niagen Bioscience and Herbalife, as provided by MarketBeat.com.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Niagen Bioscience | 0 | 1 | 3 | 1 | 3.00 |
| Herbalife | 0 | 3 | 3 | 2 | 2.88 |
Niagen Bioscience currently has a consensus target price of $10.33, indicating a potential upside of 323.50%. Herbalife has a consensus target price of $17.67, indicating a potential upside of 32.84%. Given Niagen Bioscience’s stronger consensus rating and higher possible upside, analysts plainly believe Niagen Bioscience is more favorable than Herbalife.
Volatility & Risk
Niagen Bioscience has a beta of 2.02, indicating that its share price is 102% more volatile than the S&P 500. Comparatively, Herbalife has a beta of 0.78, indicating that its share price is 22% less volatile than the S&P 500.
Institutional and Insider Ownership
15.4% of Niagen Bioscience shares are held by institutional investors. 10.0% of Niagen Bioscience shares are held by company insiders. Comparatively, 5.1% of Herbalife shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.
Summary
Niagen Bioscience beats Herbalife on 10 of the 14 factors compared between the two stocks.
About Niagen Bioscience
Niagen Bioscience, Inc. is a global bioscience company, which engages in acquiring, developing, and commercializing proprietary-based ingredient technologies. It is pioneering research on nicotinamide adenine dinucleotide (NAD+). The company’s patent portfolio includes Nicotinamide Riboside (NR) and other NAD+ precursors, which are commercialized as the flagship ingredient Niagen. It operates through the following segments: Consumer Products, Ingredients, and Analytical Reference Standards and Services. The Consumer Products segment provides finished dietary supplement products that contain the firm’s proprietary ingredients directly to consumers as well as to distributors. The Ingredients segment supplies ingredients as raw materials to the manufacturers of consumer products. The Analytical Reference Standards and Services segment includes supply of phytochemical reference standards and other research and development services. The company was founded by Mark S. Germain and Frank L. Jaksch, Jr. in 1999 and is headquartered in Los Angeles, CA.
About Herbalife
Herbalife Ltd. provides health and wellness products in North America, Mexico, South and Central America, Europe, the Middle East, Africa, China, and the Asia Pacific. It offers products in the areas of weight management; targeted nutrition; energy, sports, and fitness; outer nutrition; and literature and promotional items. The company also provides weight management products, including meal replacement products, protein shakes, drink mixes, weight loss supplements, healthy snacks, and metabolism boosting teas; targeted nutrition products, which comprise functional beverages, and dietary and nutritional supplements that contain herbs, vitamins, minerals, and other natural ingredients; outer nutrition products, such as facial skin, body, and hair care products; and energy, sports, and fitness products, including N-R-G tea and energy drink products. In addition, it offers literature, promotional, and other materials that comprise start-up kits, sales tools, and educational materials. The company sells its products through sales representatives, independent service providers, and company-operated retail platforms. Herbalife Ltd. was formerly known as Herbalife Nutrition Ltd. and changed its name to Herbalife Ltd. in April 2023. The company was founded in 1980 and is headquartered in Los Angeles, California.
Receive News & Ratings for Niagen Bioscience Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Niagen Bioscience and related companies with MarketBeat.com's FREE daily email newsletter.
